Lower-Dose stroke drug shows promise in japanese trial
NCT ID NCT00147316
First seen Jan 11, 2026 · Last updated Apr 29, 2026 · Updated 16 times
Summary
This study tested a lower dose (0.6 mg/kg) of the clot-busting drug alteplase in 103 Japanese patients who had an ischemic stroke within the past 3 hours. The goal was to see if this dose was both safe and effective in reducing disability. Results focused on how many patients had little to no disability after 3 months and how many had bleeding in the brain as a side effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL INFARCTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Cardiovascular Center
Suita, Osaka, 565-8565, Japan
Conditions
Explore the condition pages connected to this study.